Related Experiment Videos
High-affinity choline transport regulation by drug administration during postnatal development
1Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260.
Journal of Neurochemistry
|June 1, 1992
Summary
High-affinity choline transport sites, measured by [3H]hemicholinium-3 binding, show developmental regulation. Drug treatments effective in adult rats were also effective in young rats, indicating early development of regulatory mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- High-affinity choline transport sites bind [3H]hemicholinium-3.
- These sites are regulated by in vivo drug treatments, mirroring effects on acetylcholine release and choline transport.
Purpose of the Study:
- To investigate the developmental regulation of hemicholinium-3 binding sites in rat striatum and cortex.
- To examine how in vivo drug administration affects these binding sites at different developmental stages (postnatal days 5, 15, and adult).
Main Methods:
- Administration of drugs (nicotine, haloperidol, oxotremorine, pentobarbital, atropine, apomorphine) or saline intraperitoneally to rats of different ages.
- Assay of striatal and cortical membrane preparations for [3H]hemicholinium-3 binding.
- Comparison of binding levels across developmental stages and drug treatment groups.
Main Results:
- Control [3H]hemicholinium-3 binding increased significantly in striatum (days 5-15) and in both striatum and cortex (after day 15).
- Nicotine increased binding at all ages, with greater effects at day 5. Haloperidol increased binding in striatum, with larger effects at day 5.
- Oxotremorine reduced binding without developmental change, while pentobarbital reduced striatal binding with no developmental change. Atropine and apomorphine had no effect.
Conclusions:
- Drug treatments effective in adult rats were effective by postnatal day 5, suggesting early development of regulatory mechanisms.
- Cholinergic terminals in early development are regulated by similar nicotinic, muscarinic, dopaminergic, and sedative-hypnotic mechanisms as in adults.
- Observed changes in drug effect magnitude may be due to developmental differences in drug metabolism or regulation.